Classification
- Anatomical main groupAAlimentary tract and metabolism
- Therapeutic subgroupA05
- Pharmacological subgroupA05A
- Chemical subgroupA05AX
- Chemical substanceA05AX05Odevixibat
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 8 registrations
- Bylvay 1200 Microgramos Capsulas Duras1,244 mg · cápsula dura · Ipsen Pharma
- Bylvay 200 Microgramos Capsulas Duras0,207 mg · cápsula dura · Ipsen Pharma
- Bylvay 400 Microgramos Capsulas Duras0,414 mg · cápsula dura · Ipsen Pharma
- Bylvay 600 Microgramos Capsulas Duras0,622 mg · cápsula dura · Ipsen Pharma
Netherlands
CBG-MEB · 8 registrations
At a glance
- ATC code
- A05AX05
- ATC group
- Alimentary tract and metabolism
- Registers
- 8
- Registrations
- 28
- With their own page
- 28
- Companies
- 6
All medicines with Odevixibat
Human medicines from every register that match Odevixibat by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
28 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Bylvay | United States | 0.2MG, 0.6MG | capsule, pellets | Marketed | Ipsen |
| Bylvay | United States | 0.4MG, 1.2MG | capsule | Marketed | Ipsen |
| Bylvay | European Union | Authorised | Ipsen Pharma | ||
| Bylvay 1200 Microgramos Capsulas Duras | Spain | 1,244 mg | cápsula dura | Marketed | Ipsen Pharma |
| Bylvay 200 Microgramos Capsulas Duras | Spain | 0,207 mg | cápsula dura | Marketed | Ipsen Pharma |
| Bylvay 400 Microgramos Capsulas Duras | Spain | 0,414 mg | cápsula dura | Marketed | Ipsen Pharma |
| Bylvay 600 Microgramos Capsulas Duras | Spain | 0,622 mg | cápsula dura | Marketed | Ipsen Pharma |
| Kayfanda | European Union | Authorised | Ipsen Pharma | ||
| Kayfanda 1200 Microgramos Capsulas Duras | Spain | 1,244 mg | cápsula dura | Marketed | Ipsen Pharma |
| Kayfanda 200 Microgramos Capsulas Duras | Spain | 0,207 mg | cápsula dura | Marketed | Ipsen Pharma |
| Kayfanda 400 Microgramos Capsulas Duras | Spain | 0,414 mg | cápsula dura | Marketed | Ipsen Pharma |
| Kayfanda 600 Microgramos Capsulas Duras | Spain | 0,622 mg | cápsula dura | Marketed | Ipsen Pharma |
| Bylvay 1200 micorgram harde capsules | Netherlands | Capsule, hard | Authorised | Ipsen Pharma | |
| Bylvay 200 microgram harde capsules | Netherlands | Capsule, hard | Authorised | Ipsen Pharma | |
| Bylvay 400 microgram harde capsules | Netherlands | Capsule, hard | Authorised | Ipsen Pharma | |
| Bylvay 600 microgram harde capsules | Netherlands | Capsule, hard | Authorised | Ipsen Pharma | |
| KAYFANDA 1200 microgram harde capsules | Netherlands | Capsule, hard | Authorised | Ipsen Pharma | |
| KAYFANDA 200 microgram harde capsules | Netherlands | Capsule, hard | Authorised | Ipsen Pharma | |
| KAYFANDA 400 microgram harde capsules | Netherlands | Capsule, hard | Authorised | Ipsen Pharma | |
| KAYFANDA 600 microgram harde capsules | Netherlands | Capsule, hard | Authorised | Ipsen Pharma | |
| Bylvay | Canada | 1200 MCG | Capsule | Marketed | Medison Pharma Canada INC. |
| Bylvay | Canada | 400 MCG | Capsule | Marketed | Medison Pharma Canada INC. |
| Bylvay | Canada | 600 MCG | Capsule | Marketed | Medison Pharma Canada INC. |
| Bylvay | Canada | 200 MCG | Capsule | Marketed | Medison Pharma Canada INC. |
| Bylvay | Brazil | Authorised | Beaufour Ipsen Farmacêutica Ltda |